USTEKINUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MODERATE-TO-SEVERE CROHN’S DISEASE: RESULTS UP TO WEEK 104 OF THE STARDUST TRIAL

Laurent Peyrin-Biroulet  1     Severine Vermeire  2     Geert R. D'Haens  3     Julian Panés  4     Axel Dignass  5     Fernando Magro  6     Maciej Nazar  7     Manuela Le Bars  8     Marjolein Lahaye  9     Lioudmila Ni  10     Ivana Bravatà  11     Daniel R. Gaya  12     Silvio Danese  13    
1 University Hospital of Nancy, University of Lorraine, Houdemont, France
2 University Hospitals Leuven, Leuven, Belgium
3 University of Amsterdam, Academic Medical Center, Amsterdam, Netherlands
4 Hospital Clinic of Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain
5 Agaplesion Markus Hospital, Goethe University, Frankfurt/ Main, Germany
6 Hospital de São João, Porto, Portugal
7 Janssen-Cilag Polska Sp. z .o.o, Warsaw, Poland
8 Janssen-Cilag, Issy Les Moulineaux, France
9 Janssen-Cilag BV, Breda, Netherlands
10 Janssen-Cilag Russia, Moscow, Russian Federation
11 Janssen-Cilag, Milan, Italy
12 Glasgow Royal Infirmary, Glasgow, United Kingdom
13 IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Italy

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing